Frank S. Czerwiec
Sparrow Hospital(US)
Publications by Year
Research Areas
Genetic and Kidney Cyst Diseases, Electrolyte and hormonal disorders, Ion Transport and Channel Regulation, Hormonal Regulation and Hypertension, Renal and related cancers
Most-Cited Works
- → Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease(2012)1,558 cited
- → Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia(2006)1,204 cited
- → Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease(2017)592 cited
- → Vasopressin V 2 -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure(2003)430 cited
- → Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia(2010)343 cited
- → Prevalence of autosomal dominant polycystic kidney disease in the European Union(2016)239 cited
- → Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion(2011)189 cited
- → Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database(2015)189 cited
- → Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial(2017)178 cited
- → Cilostazol as a Unique Antithrombotic Agent(2003)172 cited